anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 16,321-16,350
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

16,321-16,350 of 43,093

filter-aware
13
The slide uses a structured table to demonstrate the company's track record in executing bank acquisitions.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank Beat · FinancialsLoop · Logic Chain1 hit
14
The data shows a consistent downward trend across all four capital metrics over the five-year period.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank Beat · FinancialsLoop · Logic Chain1 hit
15
The slide uses a combination of a donut chart for composition and a stacked bar chart with a line overlay for growth and cost trends.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank Beat · FinancialsLoop · Logic Chain1 hit
16
Includes footnotes regarding Q1 '21 annualization and specific adjustments for loan/securities sales.Southern States Bancshares | IPO Presentation Deck | 27 slides · Southern States Bancshares
Pitch deck Investment bank Beat · FinancialsLoop · Logic Chain1 hit
04
The slide is split into two sections: Leadership (left) and Board of Directors (right).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Team1 hit
07
Uses a central emotional photo of a patient to anchor the 'Why We Do What We Do' aspect.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
09
The slide uses an infinity loop diagram to represent the interconnected nature of the three platforms.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a bottom-up flow to connect capabilities to strategic outcomes (Speed, Safety, Cost, Quality, Efficacy).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
13
The slide uses a split-screen layout to contrast the disease state (pathophysiology) with the therapeutic intervention (product concept).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
14
Includes bar chart, line chart, and Kaplan-Meier survival curve.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · ProductLoop · Hypothesis Test1 hit
15
The slide uses bar charts with individual data points to demonstrate efficacy across three distinct physiological metrics.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
16
The slide uses a three-column layout to present histological, VCN (vector copy number), and protein expression data.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
17
The slide uses two distinct charts to show tissue specificity (bar chart) and functional efficacy (line chart with error bars).Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
18
The slide uses a process flow diagram to illustrate the scaling of manufacturing capacity.Tenaya Therapeutics | IPO Presentation Deck | 36 slides · Tenaya Therapeutics
Pitch deck Investment bank Beat · Product1 hit
05
The slide uses a grid layout to present 12 team members with headshots, names, titles, and logos of past/associated organizations.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Team1 hit
06
The slide uses a process flow to explain the 'Learning' phase of their technology platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
07
The slide title is likely a continuation from a previous slide (e.g., '...to treat patients who are not eligible for standard therapies').TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
Uses a before-after-bridge style logic to illustrate the clinical advantage of multiplexing.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a Gantt-style visualization to show the current development stage of multiple drug candidates.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a color-coded legend to distinguish between liquid and solid tumor programs.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
TScan Therapeutics | IPO Presentation Deck | 43 slidesTScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Uses a before-after-bridge framework to contrast current therapy limitations with TScan's solution.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a process flow diagram to explain a proprietary biotechnology platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a Venn diagram to explain the scope of their target discovery platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The chart demonstrates the specificity of the TargetScan platform by highlighting MAGE-A3 as the primary target with significantly higher fold-enrichment.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The chart displays fold-enrichment vs protein fragment number, identifying specific gene targets.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The slide illustrates a dual-platform approach to TCR discovery and validation.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a flow-chart style diagram to position TScan's technology as an evolution of current standard-of-care cell therapies.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
TScan Therapeutics | IPO Presentation Deck | 43 slidesTScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
Uses a Who/Why/When framework to define the market opportunity.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit